- Report
- October 2023
- 128 Pages
North America
From €3640EUR$4,000USD£3,121GBP
- Report
- October 2023
- 188 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 190 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 133 Pages
Europe
From €3640EUR$4,000USD£3,121GBP
- Report
- October 2023
- 138 Pages
Asia Pacific
From €3640EUR$4,000USD£3,121GBP
- Report
- October 2023
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 170 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 189 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 84 Pages
Canada
From €3185EUR$3,500USD£2,731GBP
- Report
- October 2023
- 81 Pages
Canada
From €3185EUR$3,500USD£2,731GBP
- Report
- October 2023
- 90 Pages
India
From €3185EUR$3,500USD£2,731GBP
- Report
- October 2023
- 90 Pages
United States
From €3185EUR$3,500USD£2,731GBP
- Report
- October 2023
- 190 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 177 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2023
- 112 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2023
- 110 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2023
- 114 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2023
- 116 Pages
Global
From €4095EUR$4,500USD£3,511GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more